Unknown OBSERVATIONAL NCT00244205

Identifying Methylation Biomarkers for Monitoring Bladder Tumors

Using PCR Technology (Polymerase Chain Reaction Technology) for Monitoring Patients With Bladder Tumors - Optimizing Genanalyses for Clinical Use.

Sponsor: Copenhagen University Hospital at Herlev

Conditions Bladder Cancer

Interventions Identifying genes methylated in urine

Updated 6 times since 2017 Last updated: Nov 14, 2005 Started: Nov 30, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00244205, this observational or N/A phase trial focuses on Bladder Cancer and remains ongoing. Sponsored by Copenhagen University Hospital at Herlev, it has been updated 6 times since 2005, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Copenhagen University Hospital at Herlev

Data source: Copenhagen University Hospital at Herlev

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Herlev, Denmark